Beehive-Derived Products for Wound Management with a Focus on Diabetic Wounds: Mechanistic Insights, Advanced Delivery Strategies, and Translational Evidence

Wound healing is a complex biological process that can be severely impaired by persistent inflammation, oxidative stress, microbial infection, impaired angiogenesis, and defective extracellular matrix remodelling. These abnormalities are particularly prominent in diabetic wounds but also contribute to delayed healing in burn, venous, pressure, traumatic, and post-surgical wounds. Beehive-derived products, including honey, propolis, royal jelly, beeswax, and bee venom, have attracted considerable interest as multifunctional natural therapeutics because of their diverse antimicrobial, antioxidant, anti-inflammatory, immunomodulatory, and regenerative activities. Honey supports wound repair through its acidic pH, high osmolarity, hydrogen peroxide generation, and bioactive phytochemicals, whereas propolis provides flavonoids and phenolic compounds that contribute to antimicrobial, antioxidant, and tissue-regenerative effects. Royal jelly promotes cellular proliferation, angiogenesis, and tissue repair, while beeswax primarily provides moisture retention, barrier protection, and structural properties in wound dressings. Bee venom and its major component, melittin, exhibit antimicrobial, anti-inflammatory, and regenerative effects, although dose-dependent toxicity and hypersensitivity remain important concerns. Recent advances in hydrogels, polymeric films, electrospun nanofibres, nanoparticles, and composite scaffolds have improved the stability, local retention, controlled release, and therapeutic performance of these products. Preclinical studies demonstrate enhanced antimicrobial activity, fibroblast migration, collagen deposition, angiogenesis, and wound closure, while emerging clinical evidence supports their potential across several wound types. However, variability in composition, standardisation, safety, formulation stability, and limited large-scale clinical evidence remain major challenges.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-10-14
DOI
https://doi.org/10.3390/ph19101632
Primary Topic
Bee Products Chemical Analysis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beehive-Derived Products for Wound Management with a Focus on Diabetic Wounds: Mechanistic Insights, Advanced Delivery Strategies, and Translational Evidence

Emad M. Abdallah, Sonia Dhiman, Raj Kamal, Neeraj Choudhary et al.
Pharmaceuticals
Bee Products Chemical Analysis
article

Beehive-Derived Products for Wound Management with a Focus on Diabetic Wounds: Mechanistic Insights, Advanced Delivery Strategies, and Translational Evidence

Emad M. Abdallah, Sonia Dhiman, Raj Kamal, Neeraj Choudhary, Ankit Awasthi, Mohit Kumar, Dinesh Kumar, Abhishek Chauhan, Hiti Narula
article en

Abstract

Wound healing is a complex biological process that can be severely impaired by persistent inflammation, oxidative stress, microbial infection, impaired angiogenesis, and defective extracellular matrix remodelling. These abnormalities are particularly prominent in diabetic wounds but also contribute to delayed healing in burn, venous, pressure, traumatic, and post-surgical wounds. Beehive-derived products, including honey, propolis, royal jelly, beeswax, and bee venom, have attracted considerable interest as multifunctional natural therapeutics because of their diverse antimicrobial, antioxidant, anti-inflammatory, immunomodulatory, and regenerative activities. Honey supports wound repair through its acidic pH, high osmolarity, hydrogen peroxide generation, and bioactive phytochemicals, whereas propolis provides flavonoids and phenolic compounds that contribute to antimicrobial, antioxidant, and tissue-regenerative effects. Royal jelly promotes cellular proliferation, angiogenesis, and tissue repair, while beeswax primarily provides moisture retention, barrier protection, and structural properties in wound dressings. Bee venom and its major component, melittin, exhibit antimicrobial, anti-inflammatory, and regenerative effects, although dose-dependent toxicity and hypersensitivity remain important concerns. Recent advances in hydrogels, polymeric films, electrospun nanofibres, nanoparticles, and composite scaffolds have improved the stability, local retention, controlled release, and therapeutic performance of these products. Preclinical studies demonstrate enhanced antimicrobial activity, fibroblast migration, collagen deposition, angiogenesis, and wound closure, while emerging clinical evidence supports their potential across several wound types. However, variability in composition, standardisation, safety, formulation stability, and limited large-scale clinical evidence remain major challenges.

PharmaceuticalsVol. 19(10)
Qassim University (SA), GNA University (IN), Chitkara University (IN)
Qassim University
Good health and well-being
Openalex Percentile: Top 14%
Bee Products Chemical Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.